These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 12505729

  • 1. Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications.
    Sindhi R, Allaert J, Gladding D, Haaland P, Koppelman B, Dunne J, Sehgal S.
    J Immunol Methods; 2003 Jan 15; 272(1-2):257-72. PubMed ID: 12505729
    [Abstract] [Full Text] [Related]

  • 2. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V, Magill A, Yost M, Janosky J, Sindhi R.
    Cytometry A; 2006 Feb 15; 69(2):95-103. PubMed ID: 16369935
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

  • 4. Cytokines and cell surface receptors as target end points of immunosuppression with cyclosporine A.
    Sindhi R, Allaert J, Gladding D, Koppelman B, Dunne JF.
    J Interferon Cytokine Res; 2001 Jul 27; 21(7):507-14. PubMed ID: 11506745
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR, Park SI, Pinheiro-Machado PG, Garcia R, Casarini DE, Moreira S, Tedesco-Silva H, Medina-Pestana JO.
    Fundam Clin Pharmacol; 2009 Oct 27; 23(5):625-31. PubMed ID: 19656203
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME, Tejpal N, Qu X, Yu J, Okamoto M, Stepkowski SM, Kahan BD.
    Transplantation; 1998 Apr 15; 65(7):899-905. PubMed ID: 9565092
    [Abstract] [Full Text] [Related]

  • 7. Preclinical results of sirolimus treatment in transplant models.
    Stepkowski SM.
    Transplant Proc; 2003 May 15; 35(3 Suppl):219S-226S. PubMed ID: 12742499
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamics of T-cell function for monitoring immunosuppression.
    Barten MJ, Tarnok A, Garbade J, Bittner HB, Dhein S, Mohr FW, Gummert JF.
    Cell Prolif; 2007 Feb 15; 40(1):50-63. PubMed ID: 17227295
    [Abstract] [Full Text] [Related]

  • 9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 10. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen.
    Sindhi R, LaVia MF, Paulling E, McMichael J, Burckart G, Shaw S, Sindhi LA, Livingston R, Sehgal S, Jaffe J.
    Transplantation; 2000 Feb 15; 69(3):432-6. PubMed ID: 10706056
    [Abstract] [Full Text] [Related]

  • 11. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
    Stepkowski SM, Napoli KL, Wang ME, Qu X, Chou TC, Kahan BD.
    Transplantation; 1996 Oct 15; 62(7):986-94. PubMed ID: 8878394
    [Abstract] [Full Text] [Related]

  • 12. The pharmacodynamic effect of sirolimus: individual variation of cytokine mRNA expression profiles in human whole blood samples.
    Müller-Steinhardt M, Wortmeier K, Fricke L, Ebel B, Härtel C.
    Immunobiology; 2009 Oct 15; 214(1):17-26. PubMed ID: 19159823
    [Abstract] [Full Text] [Related]

  • 13. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 14. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM, Tian L, Napoli KL, Ghobrial R, Wang ME, Chou TC, Kahan BD.
    Clin Exp Immunol; 1997 Apr 15; 108(1):63-8. PubMed ID: 9097913
    [Abstract] [Full Text] [Related]

  • 15. Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial.
    Oberbauer R, Hutchison B, Eris J, Arias M, Claesson K, Mota A, Kreis H, Kleinman L, Wang F, Chen J, Revicki DA, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Apr 27; 75(8):1277-85. PubMed ID: 12717216
    [Abstract] [Full Text] [Related]

  • 16. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 17. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
    Johnson RW, Kreis H, Oberbauer R, Brattström C, Claesson K, Eris J.
    Transplantation; 2001 Sep 15; 72(5):777-86. PubMed ID: 11571437
    [Abstract] [Full Text] [Related]

  • 18. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
    Bohra R, Schöning W, Klawitter J, Brunner N, Schmitz V, Shokati T, Lawrence R, Arbelaez MF, Schniedewind B, Christians U, Klawitter J.
    PLoS One; 2012 Sep 15; 7(10):e48063. PubMed ID: 23118926
    [Abstract] [Full Text] [Related]

  • 19. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
    Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2005 Nov 15; 80(9):1204-11. PubMed ID: 16314787
    [Abstract] [Full Text] [Related]

  • 20. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S, Brunner LJ, Stepkowski SM, Napoli KL, Kahan BD.
    Transplantation; 2001 Jun 15; 71(11):1585-92. PubMed ID: 11435969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.